Skip to main content
Caplight Logo









Clinikally

Clinikally

Private
IndiaHealthcare & Life Scienceshttps://www.clinikally.com/

Last Round

Seed

Sep 29, 2023

Total Funding Raised

$3.1M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Clinikally is a digital health company that provides a telemedicine platform and online pharmacy specifically for dermatology patients, offering AI-driven diagnostics and a range of affordable healthcare products in dermatology, nutrition, and wellness.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, E-commerce, Fashion & Beauty, Patient Engagement, D2C Brands

Business Model

B2C

Customer Profile

Marketplace Commission, Services & Consulting

AI Layer

Application

Keywords

tele-dermatologyskincare marketplaced2c skincareomnichannel healthcaretelehealthdermatology clinicderma startupskin healthvirtual consultationdigital healthemployee wellnessskin analysis AIbeauty techclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Clinikally Comparables

Compare Clinikally with similar companies based on industry and business-model similarity.

Clinikally comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CureSkin
84%
GetHarley
79%
Mosaic Wellness
78%

Clinikally Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 29, 2023
SeedJul 19, 2022

Key People

Founding team and executive leadership

Harmeet Singh Khanuja

Chief Financial Officer

Executive Team

Clinikally Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 13, 2026

    Launched offline 'Clinikally Experience Centers' in Delhi NCR and Punjab.

  • Jun 13, 2026

    Served over 3 million users in 3.5 years.

Recent news

Latest coverage and updates

  • has_revenueSep 2, 2026

    Clinikally had revenue of $9.9M on Jul 1st '24.

Clinikally Filings

Explore SEC and related filing metadata, where available.

Clinikally filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Clinikally's valuation, stock price, and market status.

Is Clinikally a public or private company?

Clinikally is a private company.

What is the current stock price of Clinikally?

Clinikally is a private company with no public stock price. No recent secondary market data is available.

How much is Clinikally worth (valuation)?

Valuation information for Clinikally is not publicly available.

Can I buy Clinikally stock?

Clinikally shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Clinikally's last funding round?

Clinikally's most recent funding round was Seed on September 29, 2023.

Who are the main investors in Clinikally?

Key investors in Clinikally include Goodwater Capital, Tribe Capital, Y Combinator, Rebel Fund.

Will Clinikally IPO soon?

No public IPO plans have been announced for Clinikally.

How can I track Clinikally secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clinikally's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIndia
Employee Range124
Year Founded2021
Last FundingSep 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?